Tocilizumab may improve survival in sickest COVID-19 patients, scientists say

Tocilizumab, a drug normally used in rheumatoid arthritis and cancer treatments, may improve hospital survival in critically-ill COVID-19 patients admitted to the intensive care unit (ICU), according to an observational study of more than 600 people infected with the novel coronavirus.




Read the Rest at INDIA TV

Leave a Reply

Your email address will not be published. Required fields are marked *